HBM Partners
Priyanka Belawat serves as a Partner at HBM Partners since February 2007, focusing on investments in oncology and specialty pharmaceuticals. Notable recent board memberships include IO Biotech, Bioatla, iTeos, Neurelis Inc, and Adrenomed, showcasing expertise in drug development and epilepsy treatment. Additionally, Priyanka held a board member position at South Pole from June 2022 to October 2023 and has previously participated on the boards of Bioatla and iTeos Therapeutics. Educational background includes a Doctorate in Genetics and Molecular Biology from the University of Zurich, completed in 2006.
This person is not in any teams